FDA to tighten vaccine approval
Digest more
CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company’s ...
CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The approval is for children aged 6 months to 11 years ...
WASHINGTON -- Moderna is applying for full government approval for its COVID-19 vaccine. The company said it is submitting trial data to the Food and Drug Administration on a rolling basis over ...
Investor's Business Daily on MSN
Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10
Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results